Dr. Andrew Gard, MD
Claim this profileUniversity of Nebraska
Studies Subdural Hematoma
Studies Hematoma
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Andrew Gard, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Andrew Gard, MD has experience with
- SQUID
Breakdown of trials Andrew Gard, MD has run
Subdural Hematoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Gard, MD specialize in?
Andrew Gard, MD focuses on Subdural Hematoma and Hematoma. In particular, much of their work with Subdural Hematoma has involved treating patients, or patients who are undergoing treatment.
Is Andrew Gard, MD currently recruiting for clinical trials?
No, Andrew Gard, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Andrew Gard, MD has studied deeply?
Yes, Andrew Gard, MD has studied treatments such as SQUID.
What is the best way to schedule an appointment with Andrew Gard, MD?
Apply for one of the trials that Andrew Gard, MD is conducting.
What is the office address of Andrew Gard, MD?
The office of Andrew Gard, MD is located at: University of Nebraska, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.